Phantom Limb Pain on Post-Surgical Amputation Osteosarcoma Children Patient

Bagus Pratama; Jason Mikail Amper; Gatra Hadimuti Wibowo; Rogatianus Bagus Pratignyo

Authors

Bagus Pratama Fakultas Kedokteran, Universitas Lampung https://orcid.org/0000-0002-1646-0736
Jason Mikail Amper Fakultas Kedokteran, Universitas Lampung
Gatra Hadimuti Wibowo Fakultas Kedokteran, Universitas Lampung
Rogatianus Bagus Pratignyo Fakultas Kedokteran, Universitas Lampung

Keywords:

Osteosarkoma, Postamputasi, Pediatrik, Phantom Limb Pain, Penatalaksanaan

Abstract

Osteosarcoma is a musculoskeletal malignancy that often occurs in pediatric patients requiring multidisciplinary management. Management in the form of amputation surgery (limb-salvage surgery) with a combination of chemotherapy or radiotherapy. Post-amputation complications that are often experienced by patient is postsurgical pain. Persistent Postsurgical Pain (PPSP) in pediatric patients is influenced by risk factors such as age, gender, preoperative preparation (pain intensity, anxiety, pain efficacy), intraoperative measures (site of surgery, potential for nerve damage, administration of analgesia regimens, technique of anesthesia), and postoperative management. The incidence of PPSP in osteosarcoma postamputation patients is related to Phantom Limb Syndrome with varying incidence and duration. This syndrome is a phenomenon that often occurs after post-amputation procedures in the form of sensation (Phantom Limb Sensation) or pain (Phantom Limb Pain) due to loss of part of the body. Phantom Limb Pain (PLP) is an effect and complication that occurs after amputation surgery in pediatric osteosarcoma patients. The PLP pathomechanism is related to the interaction of the Central Nervous System (Cortical Remapping Theory and Proprioceptive Theory) and the Peripheral Nervous System (Dorsal Root Ganglia and nocireceptor stimulation). Management of PLP consists of neuropathic pain medications such as antidepressants, opioids, anticonvulsants, N-methyl-D-aspartate (NMDA) receptor antagonists and other anesthetic agents.

References

Durfee, R.A., Mohammed, M., Luu, H.H., 2016. Review of osteosarcoma and current management. Rheumatology and therapy. 3(2):221-43.

Mirabello, L., Troisi, R.J., Savage, S.A., 2009. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2009;115(7):1531-43.

Expert Committee of Osteosarcoma, Chinese Society of Clinical Oncology (CSCO), Sarcoma Committee of Chinese Association against Cancer. 2012. Consensus of clinical experts on typical osteosarcoma. J Clin Oncol, 17:931-3

Sadykova, L. R., et al., 2020. Epidemiology and risk factors of osteosarcoma. Cancer Investigation, 1–14. doi:10.1080/07357907.2020.1768401

Huang, J., Bi, W., Han, G., Jia, J., Xu, M., & Wang, W., 2018. The multidisciplinary treatment of osteosarcoma of the proximal tibia: a retrospective study. BMC Musculoskeletal Disorders, 19(1). doi:10.1186/s12891-018-2245-x

Xu, M., Wang, Z., Yu, X., Lin, J., & Hu, Y., 2020. Guideline for Limb‐Salvage Treatment of Osteosarcoma. Orthopaedic Surgery. doi:10.1111/os.12702

Ta, H.T., Dass, C.R., Choong, P.F., Dunstan, D.E., 2009. Osteosarcoma treatment: state of the art. Cancer and Metastasis Reviews. 2009;28(1-2):247-63

Pala E., et al., 2013. Survival of current production tumor endoprostheses: complications, functional results, and a comparative statistical analysis. J Surg Oncol, 2013, 108: 403–408

Tacyildiz, N., et. al., 2021. Late effects of osteosarcoma and its treatment in pediatric patients: A single-center experience. JBUON 2021; 26(3): 1102-1110 ISSN: 1107-0625, online ISSN: 2241-6293

Nikolajsen, L., Brix, L.D., 2014. Chronic pain after surgery in children. Curr Opin Anaesthesiol 2014;27:507–12.

Rabbitts, J.A., Fisher, E., Rosenbloom, B.N., Palermo, T.M., 2017. Prevalence and predictors of chronic postsurgical pain in children: a systematic review and meta-analysis. J Pain 2017;18:605–14

Anghelescu DL, et al., 2016. Mirror therapy for phantom limb pain at a pediatric oncology institution. Rehabil Oncol 2016;34:104–10

Burgoyne LL, et al., 2012. Phantom limb pain in young cancer-related amputees: recent experience at St. Jude Children's Research Hospital. Clin J Pain 2012;28:222–5.

Poor Zamany Nejatkermany M, Modirian E, Soroush M, Masoumi M, Hosseini M., 2016. Phantom limb sensation (PLS) and phantom limb pain (PLP) among young landmine amputees. Iran J Child Neurol. 10:42–7

Hsu E, Cohen SP., 2013. Postamputation pain: epidemiology, mechanisms, and treatment. J Pain Res. 6:121–36. doi:10.2147/JPR.S32299

Ferraro, F., et al., 2016. Diagnosis and treatment of pain in plexopathy, radiculopathy, peripheral neuropathy and phantom limb pain. Evidence and recommendations from the Italian Consensus Conference on Pain on Neurorehabilitation. Eur J Phys Rehabil Med. 52:855–66.

DeMoss, P., Ramsey, LH., Karlson, CW., 2018. Phantom Limb Pain in Pediatric Oncology. Front Neurol. 2018;9:219

Hillebrand, M., Collier, T., 2021. Pediatric Acquired Upper and Lower Limb Deficiency. PM&R knowledge now.

Rothgangel A, Braun S, Winkens B, et al., 2018. Traditional and augmented reality mirror therapy for patients with chronic phantom limb pain (PACT study): Results of a three-group, multicentre single-blind randomized controlled trial. Clin Rehabil. 2018;32(12):1591–608. 10.1177/0269215518785948

Rostaminejad A, Behnammoghadam M, Rostaminejad M, et al., 2017. Efficacy of eye movement desensitization and reprocessing on the phantom limb pain of patients with amputations within a 24-month follow-up. Int J Rehabil Res. 2017;40(3):209–14. 10.1097/MRR.0000000000000227

Dumanian GA, Potter BK, Mioton LM, et al., 2019. Targeted Muscle Reinnervation Treats Neuroma and Phantom Pain in Major Limb Amputees: A Randomized Clinical Trial. Ann Surg. 2019;270(2):238–246. 10.1097/SLA.0000000000003088

Brunelli S, Morone G, Iosa M, et al., 2015. Efficacy of progressive muscle relaxation, mental imagery, and phantom exercise training on phantom limb: a randomized controlled trial. Arch Phys Med Rehabil. 2015;96(2):181–7. 10.1016/j.apmr.2014.09.035

Ottaviani, G., & Jaffe, N., 2009. The Epidemiology of Osteosarcoma. Pediatric and Adolescent Osteosarcoma, 3–13. doi:10.1007/978-1-4419-0284-9_1

Zheng, W., et al., 2018. Nomogram application to predict overall and cancer-specific survival in osteosarcoma. Cancer management and research, 10, 5439–5450. https://doi.org/10.2147/CMAR.S177945

Nikolajsen, L., & Christensen, K. F., 2015. Phantom Limb Pain. Nerves and Nerve Injuries, 23–34. doi:10.1016/b978-0-12-802653-3.00051-8

Aternali, A., Katz, J., 2019. Recent advances in understanding and managing phantom limb pain. F1000Research, 8, 1167. doi:10.12688/f1000research.19355

Richardson, C., et al., 2015. A clinical evaluation of postamputation phenomena including phantom limb pain after lower limb amputation in Dysvascular patients. Pain Manag Nurs 16:561–569

Aldington, D., et al., 2014. A survey of postamputation pains in serving military personnel. J R Army Med Corps 160:38–41

Kuffler, D.P., 2018. Coping with Phantom Limb Pain. Mol Neurobiol 55, 70–84. https://doi.org/10.1007/s12035-017-0718-9

Makin TR, Scholz J, Henderson Slater D, Johansen-Berg H, Tracey I, 2015. Reassessing cortical reorganization in the primary sensorimotor cortex following arm amputation. Brain. 2015;138(Pt 8):2140–2146.

Liu, Y., 2020. The pathophysiology of phantom limb pain. Atlantis Press. ICHESS 2020.

Collins, K. L., et al., 2018. A review of current theories and treatments for phantom limb pain. Journal of Clinical Investigation, 128(6), 2168–2176. doi:10.1172/jci94003

Vaso A, et al., 2014. Peripheral nervous system origin of phantom limb pain. Pain. 2014;155(7):1384–1391.

Du X, et al., 2017. Local GABAergic signaling within sensory ganglia controls peripheral nociceptive transmission. J Clin Invest. 2017;127(5):1741–1756.

Sekonyela-Rakolanyana, R., Hunziker, S., 2019. Managing phantom limb pain with medication. Practical Pain Management Journal. Volume 19 Issue 5.

Ferguson, K., Wolfgram, N., 2019. Antidepressants in Pain Management. In: Deer, T., Pope, J., Lamer, T., Provenzano, D. (eds) Deer's Treatment of Pain. Springer, Cham. https://doi.org/10.1007/978-3-030-12281-2_23

Steen, T., Lirk, P. B., & Sigurdsson, M. I., 2019. The demographics of persistent opioid consumption following limb amputation. Acta Anaesthesiologica Scandinavica. doi:10.1111/aas.13497

Jiang, S., Zhou, Mm., Xia, R. et al., 2021. Gabapentin for phantom limb pain after amputation in pediatric oncology: a systematic review protocol. Syst Rev 10, 26 (2021). https://doi.org/10.1186/s13643-020-01571-8

Kreutzwiser, D., Tawfic, Q.A., 2019. Expanding Role of NMDA Receptor Antagonists in the Management of Pain. CNS Drugs 33, 347–374 (2019). https://doi.org/10.1007/s40263-019-00618-2

Magee, D. J., Jhanji, S., Poulogiannis, G., Farquhar-Smith, P., & Brown, M. R. D., 2019. Nonsteroidal anti-inflammatory drugs and pain in cancer patients: a systematic review and reappraisal of the evidence. British Journal of Anaesthesia. doi:10.1016/j.bja.2019.02.028

Sturma, A., Hruby, L., Vujaklija, I., Østlie, K., Farina, D., 2021. Treatment Strategies for Phantom Limb Pain. In: Aszmann, O.C., Farina, D. (eds) Bionic Limb Reconstruction. Springer, Cham. https://doi.org/10.1007/978-3-030-60746-3_12

Anghelescu, D. L., & Tesney, J. M., 2019. Neuropathic Pain in Pediatric Oncology: A Clinical Decision Algorithm. Pediatric Drugs. doi:10.1007/s40272-018-00324-4